These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2945 related items for PubMed ID: 18654426
1. Nanocarriers as an emerging platform for cancer therapy. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426 [Abstract] [Full Text] [Related]
2. Nanotechnology platforms and physiological challenges for cancer therapeutics. Kim KY. Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621 [Abstract] [Full Text] [Related]
3. Nanomedicine: nanocarriers shape up for long life. Nishiyama N. Nat Nanotechnol; 2007 Apr; 2(4):203-4. PubMed ID: 18654260 [No Abstract] [Full Text] [Related]
5. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents. Juliano RL, Alam R, Dixit V, Kang HM. Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009 Apr; 1(3):324-35. PubMed ID: 20049800 [Abstract] [Full Text] [Related]
6. Is nanotechnology ready for primetime? Brower V. J Natl Cancer Inst; 2006 Jan 04; 98(1):9-11. PubMed ID: 16391365 [No Abstract] [Full Text] [Related]
7. Nanotechnological applications in medicine. Caruthers SD, Wickline SA, Lanza GM. Curr Opin Biotechnol; 2007 Feb 04; 18(1):26-30. PubMed ID: 17254762 [Abstract] [Full Text] [Related]
8. Nanomedicine in cancer treatment. Yih TC, Wei C. Nanomedicine; 2005 Jun 04; 1(2):191-2. PubMed ID: 17292078 [No Abstract] [Full Text] [Related]
9. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Namiki Y, Fuchigami T, Tada N, Kawamura R, Matsunuma S, Kitamoto Y, Nakagawa M. Acc Chem Res; 2011 Oct 18; 44(10):1080-93. PubMed ID: 21786832 [Abstract] [Full Text] [Related]
10. Multifunctional nanocarriers. Torchilin VP. Adv Drug Deliv Rev; 2006 Dec 01; 58(14):1532-55. PubMed ID: 17092599 [Abstract] [Full Text] [Related]
11. Advances in Nanocarriers for Anticancer Drugs Delivery. Ali I, Lone MN, Suhail M, Mukhtar SD, Asnin L. Curr Med Chem; 2016 Dec 01; 23(20):2159-87. PubMed ID: 27048343 [Abstract] [Full Text] [Related]
13. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link? Taurin S, Nehoff H, Greish K. J Control Release; 2012 Dec 28; 164(3):265-75. PubMed ID: 22800576 [Abstract] [Full Text] [Related]
14. Polymer conjugates: nanosized medicines for treating cancer. Vicent MJ, Duncan R. Trends Biotechnol; 2006 Jan 28; 24(1):39-47. PubMed ID: 16307811 [Abstract] [Full Text] [Related]
15. Delivering cancer stem cell therapies - a role for nanomedicines? Schätzlein AG. Eur J Cancer; 2006 Jun 28; 42(9):1309-15. PubMed ID: 16682183 [Abstract] [Full Text] [Related]
16. Anticancer drug delivery with nanoparticles. Conti M, Tazzari V, Baccini C, Pertici G, Serino LP, De Giorgi U. In Vivo; 2006 Jun 28; 20(6A):697-701. PubMed ID: 17203748 [Abstract] [Full Text] [Related]
17. Role of nanocarrier systems in cancer nanotherapy. Mozafari MR, Pardakhty A, Azarmi S, Jazayeri JA, Nokhodchi A, Omri A. J Liposome Res; 2009 Jun 28; 19(4):310-21. PubMed ID: 19863166 [Abstract] [Full Text] [Related]
18. Using nanotechnology to improve the characteristics of antineoplastic drugs: improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel. Foote M. Biotechnol Annu Rev; 2007 Jun 28; 13():345-57. PubMed ID: 17875482 [Abstract] [Full Text] [Related]
19. Nanomedicine and drug delivery. Wei C, Wei W, Morris M, Kondo E, Gorbounov M, Tomalia DA. Med Clin North Am; 2007 Sep 28; 91(5):863-70. PubMed ID: 17826106 [Abstract] [Full Text] [Related]
20. [Peptide aptamers and nano-carriers for cancer therapy]. Shiba K. Gan To Kagaku Ryoho; 2009 Mar 28; 36(3):362-5. PubMed ID: 19295259 [Abstract] [Full Text] [Related] Page: [Next] [New Search]